当前位置:首页 - 行情中心 - 江中药业(600750) - 财务分析 - 现金流量表

江中药业

(600750)

  

流通市值:167.42亿  总市值:168.47亿
流通股本:6.25亿   总股本:6.29亿

现金流量表

报告期2024-03-312023-12-312023-09-302023-06-30
公司类型通用通用通用通用
一、经营活动产生的现金流量:
销售商品、提供劳务收到的现金882,563,080.124,727,512,323.783,185,367,357.192,415,819,862.23
收到的税费返还2,075.2224,160,105.5623,579,223.7221,664,682.5
收到其他与经营活动有关的现金68,722,376.0539,248,083.7783,656,633.570,499,930.54
经营活动现金流入的平衡项目0000
经营活动现金流入小计951,287,531.394,790,920,513.113,292,603,214.412,507,984,475.27
购买商品、接受劳务支付的现金191,881,680.911,128,192,184.95724,262,392.13521,139,017.44
支付给职工以及为职工支付的现金242,766,007.51658,534,050.46484,335,809.57360,027,865.49
支付的各项税费144,074,702.16501,937,765.21394,459,409.85290,977,216.03
支付其他与经营活动有关的现金289,979,728.151,466,356,948.541,118,575,097.66805,533,437.1
经营活动现金流出的平衡项目0000
经营活动现金流出小计868,702,118.733,755,020,949.162,721,632,709.211,977,677,536.06
经营活动产生的现金流量净额平衡项目0000
经营活动产生的现金流量净额82,585,412.661,035,899,563.95570,970,505.2530,306,939.21
二、投资活动产生的现金流量:
收回投资收到的现金330,000,0001,880,151,763.581,596,000,0001,249,000,000
取得投资收益收到的现金18,186,985.2941,919,500.937,799,073.1414,276,740.24
处置固定资产、无形资产和其他长期资产收回的现金净额11,793.41245,970.113,480.52100
投资活动现金流入的平衡项目0000
投资活动现金流入小计348,198,778.71,922,317,234.591,633,802,553.661,263,276,840.24
购建固定资产、无形资产和其他长期资产支付的现金55,460,349.64208,878,673.24153,152,541.0996,064,638.66
投资支付的现金360,000,0001,840,473,543.311,998,747,645.151,124,864,083.51
投资活动现金流出的平衡项目0000
投资活动现金流出小计415,460,349.642,049,352,216.552,151,900,186.241,220,928,722.17
投资活动产生的现金流量净额平衡项目0000
投资活动产生的现金流量净额-67,261,570.94-127,034,981.96-518,097,632.5842,348,118.07
三、筹资活动产生的现金流量:
分配股利、利润或偿付利息支付的现金-800,502,545.35416,390,683.5409,139,222.7
支付其他与筹资活动有关的现金550,736.8416,545,307.142,320,654.471,889,311.05
筹资活动现金流出平衡项目0000
筹资活动现金流出小计550,736.84817,047,852.49418,711,337.97411,028,533.75
筹资活动产生的现金流量净额平衡项目0000
筹资活动产生的现金流量净额-550,736.84-817,047,852.49-418,711,337.97-411,028,533.75
现金及现金等价物净增加额平衡项目0000
五、现金及现金等价物净增加额14,773,104.8891,816,729.5-365,838,465.35161,626,523.53
加:期初现金及现金等价物余额642,140,896.15550,324,166.65550,324,166.65550,324,166.65
期末现金及现金等价物余额平衡项目0000
期末现金及现金等价物余额656,914,001.03642,140,896.15184,485,701.3711,950,690.18
补充资料:
净利润-766,663,646.9-474,136,629.67
资产减值准备-8,853,990.82--4,951.72
固定资产和投资性房地产折旧-101,232,038.46-49,787,969.5
其中:固定资产折旧、油气资产折耗、生产性生物资产折旧-101,232,038.46-49,787,969.5
无形资产摊销-18,386,790.19-8,747,042.61
长期待摊费用摊销-855,196.82-616,478.32
处置固定资产、无形资产和其他长期资产的损失--1,219,015.36--5,238.73
固定资产报废损失-2,011,844.97-64,340.2
公允价值变动损失-37,108,486.56--17,209,180.43
财务费用--61,066,959.39--27,213,120.32
投资损失-2,937,648.04-158,589.57
递延所得税--13,143,709.05-1,445,245.28
其中:递延所得税资产减少--9,051,811.1-2,608,166.75
递延所得税负债增加--4,091,897.95--1,162,921.47
存货的减少--28,123,517.05-13,158,913.62
经营性应收项目的减少-291,453,290.24-159,254,627.57
经营性应付项目的增加--101,835,515.59--133,498,387.08
其他-8,943,065.82-4,616,356.37
现金的期末余额-642,140,896.15-711,950,690.18
减:现金的期初余额-550,324,166.65-550,324,166.65
公告日期2024-04-272024-03-232023-10-282023-08-24
审计意见(境内)标准无保留意见
TOP↑